SUBSCRIBERS
Long-term view allows Temasek to be patient with poor performers
Published Tue, Jul 9, 2019 · 09:50 PM
Singapore
TEMASEK Holdings can stay the course with its poor performers because it invests for the long term.
The point was made at Temasek's annual review on Tuesday, after shares of German life science giant Bayer had fallen by 39 per cent since April 2018, when Temasek put an additional three billion euros (S$4.8 billion) into the company.
Copyright SPH Media. All rights reserved.